Skip to content

MapLight Therapeutics, Inc. MPLT Noncash Lease Expense

Noncash Lease Expense at other companies

Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$980K+14.4%
HRO
HarrowHROW
$192K-11.5%
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
$125K+42.0%
Kohl's logo
Kohl'sKSS
$22M+4.8%
Remitly Global, Inc. logo
Remitly Global, Inc.RELY
$765K-20.2%
Rush Street Interactive logo
Rush Street InteractiveRSI
$265K+18.3%

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B
Enterprise value$1.34B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept mplt:NoncashLeaseExpense.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's noncash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's noncash lease expense?
MapLight Therapeutics, Inc. (MPLT) reported noncash lease expense of $229K in Q1 2026.
What does noncash lease expense mean?
This represents the portion of lease expenses that does not involve an immediate cash outflow, typically associated with the amortization of right-of-use assets. It is added back to net income in the operating section of the cash flow statement to reconcile accounting expenses with cash-based operations. This metric helps isolate the impact of lease accounting standards on reported profitability.